rhodioloside has been researched along with sb 202190 in 1 studies
Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (sb 202190) | Trials (sb 202190) | Recent Studies (post-2010) (sb 202190) |
---|---|---|---|---|---|
621 | 2 | 519 | 651 | 0 | 202 |
Protein | Taxonomy | rhodioloside (IC50) | sb 202190 (IC50) |
---|---|---|---|
Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.08 | |
Bromodomain-containing protein 4 | Homo sapiens (human) | 2.95 | |
Tyrosinase | Mus musculus (house mouse) | 0.03 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.08 | |
Casein kinase I isoform delta | Homo sapiens (human) | 0.188 | |
Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.08 | |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.1038 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0625 | |
Tau-tubulin kinase 2 | Homo sapiens (human) | 9.34 | |
large T antigen | Betapolyomavirus macacae | 4.87 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, J; Zhang, YL; Zhuang, N | 1 |
1 other study(ies) available for rhodioloside and sb 202190
Article | Year |
---|---|
[Salidroside inhibits inflammatory factor release in BV-2 cells through p38 and JNK pathways].
Topics: Animals; Anthracenes; Apoptosis; Cell Survival; Cells, Cultured; Glucosides; Imidazoles; Inflammation; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Microglia; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Pyridines; Tumor Necrosis Factor-alpha | 2018 |